Advertisements


Prana to start Phase 1 clinical trial study of PBT434

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

Catalyst Enrolls First Patient in Phase III Firdapse Study

Catalyst (CPRX) enrolls the first patient in its phase III clinical trial (MSK-002) to evaluate the efficacy and safety of Firdapse in patients with MuSK antibody positive Myasthenia Gravis. Catalyst Pharmaceuticals, Inc. CPRX, enroled.....»»

Category: worldSource: nytApr 20th, 2018

Blueprint Medicines initiates Voyager Phase 3 clinical trial of Avapritinib

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 21st, 2018

Trovagene starts enrollment for Phase 2 clinical trial of PCM-075 in mCRPC

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 21st, 2018

Atossa completes all dosing, clinical visits in topical Endoxifen Phase 1 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 20th, 2018

Sarepta shares rocket 55% on positive early results for DMD gene therapy

Sarepta Therapeutics Inc. shares rocketed 55.6% in extremely heavy Tuesday morning trade after the company reported positive early results from a phase 1/2a gene therapy clinical trial for three patients with the rare.....»»

Category: topSource: marketwatchJun 19th, 2018

ObsEva EDELWEISS Phase 2b clinical trial achieve primary, secondary endpoints

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2018

Solid Biosciences says FDA has removed clinical hold on SGT-001 DMD treatment

Solid Biosciences Inc. said Monday the U.S. Food and Drug Administration has lifted its clinical hold on SGT-001, the company's treatment for Duchenne muscular dystrophy, allowing a Phase 1/11 trial to res.....»»

Category: topSource: marketwatchJun 18th, 2018

Cytokinetics announces data from reldesemtiv Phase 2 clinical study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 18th, 2018

Cytokinetics announces data from Phase 2 clinical study of Reldesemtiv in SMA

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 17th, 2018

Idera Stock Down, Study on Dermatomyositis Candidate Fails

Shares of Idera (IDRA) decline following the failure of a phase II study of its pipeline candidate, IMO-8400, on adult patients with dermatomyositis. Idera Pharmaceuticals Inc IDRA announced that the phase II clinical study, eva.....»»

Category: smallbizSource: nytJun 13th, 2018

Seattle Genetics announces dosing in Phase 2 innovaTV 204 clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2018

OncoMed doses first patient in Phase 1b portion of anti-TIGIT clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Aevi Genomics Medicine to increase sample size in Phase 2 Ascend clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Surface Oncology initiated Phase I clinical trial of SRF373 / NZV930

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Pluristem reports "positive" results from Phase II clinical study of PLX-PAD

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Aquinox initiates ProShip Phase 2 proof-of-concept clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 11th, 2018

MannKind Completes Phase 1 Clinical Trial On Treprostinil Product

MannKind Completes Phase 1 Clinical Trial On Treprostinil Product.....»»

Category: topSource: seekingalphaJun 7th, 2018

MannKind completes Phase 1 clinical study of Treprostinil

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 7th, 2018

Nightstar Therapeutics Reports First Quarter 2018 Financial Results and Acceleration of Preliminary NSR-RPGR Readout to Third Quarter 2018

Preliminary data from dose escalation study in the Phase 1/2 XIRIUS trial for X-Linked Retinitis Pigm.....»»

Category: earningsSource: benzingaJun 6th, 2018

Viking Therapeutics completes enrollment in Phase 2 clinical trial of VK2809

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2018